Published in Ocul Immunol Inflamm on October 01, 2010
A comparative study between clinical grading of anterior chamber flare and flare reading using the Kowa laser flare meter. Int Ophthalmol (2012) 0.91
A Rayleigh Scatter-Based Ocular Flare Analysis Meter for Flare Photometry of the Anterior Chamber. Transl Vis Sci Technol (2015) 0.75
Does the disruption of horizontal anterior ciliary vessels affect the blood-aqueous barrier function? Graefes Arch Clin Exp Ophthalmol (2017) 0.75
Laser flare-cell photometer: principle and significance in clinical and basic ophthalmology. Jpn J Ophthalmol (2016) 0.75
Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet (2010) 3.24
Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet (2013) 1.93
Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol (2008) 1.92
Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum (2010) 1.84
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology (2013) 1.81
Clinical features and outcomes of HLA-b27-positive and HLA-B27-negative acute anterior uveitis in a Turkish patient population. Ocul Immunol Inflamm (2006) 1.62
Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol (2006) 1.47
The use of interferon alpha in Behçet disease: review of the literature. Semin Arthritis Rheum (2004) 1.44
Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res (2011) 1.35
Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology (2010) 1.34
Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Ann Rheum Dis (2011) 1.26
Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm (2009) 1.25
The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis. Br J Ophthalmol (2010) 1.25
Behçet's disease: ocular effects and treatment. Prog Retin Eye Res (2007) 1.17
Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial. Semin Arthritis Rheum (2004) 1.17
Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease. Proc Natl Acad Sci U S A (2013) 1.15
Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol (2008) 1.11
Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol (2007) 1.09
Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity). Int Ophthalmol (2012) 1.08
Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography. Klin Monbl Augenheilkd (2002) 1.08
Work-up, diagnosis and management of acute Vogt-Koyanagi-Harada disease: a case of acute myopization with granulomatous uveitis. Int Ophthalmol (2007) 1.08
A clinical approach to the diagnosis of retinal vasculitis. Int Ophthalmol (2009) 1.08
Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation. Int Ophthalmol (2009) 1.08
Rosacea - S1 guideline. J Dtsch Dermatol Ges (2013) 1.06
Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis. Int Ophthalmol (2008) 1.02
Conjunctival ulcers in Behçet's disease. Ophthalmology (2003) 1.01
Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol (2005) 1.00
Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol (2007) 1.00
Patterns of uveitis in the middle East and europe. J Ophthalmic Vis Res (2011) 0.98
Massive vascular endothelium growth factor (VEGF) expression in Eales' disease. Klin Monbl Augenheilkd (2002) 0.98
Fuchs' Uveitis: Failure to Associate Vitritis and Disc Hyperfluorescence with the Disease is the Major Factor for Misdiagnosis and Diagnostic Delay. Middle East Afr J Ophthalmol (2009) 0.97
Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm (2011) 0.96
Central serous chorioretinopathy, corticosteroids, and uveitis. Ocul Immunol Inflamm (2012) 0.95
Indocyanine green angiography guided management of vogt-koyanagi-harada disease. J Ophthalmic Vis Res (2011) 0.95
Diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm (2010) 0.94
Optical coherence tomography imaging in uveitis. Int Ophthalmol (2013) 0.94
CNS diseases and uveitis. J Ophthalmic Vis Res (2011) 0.93
Cotton wool spots as possible indicators of retinal vascular pathology in ocular lyme borreliosis. Int Ophthalmol (2008) 0.92
[Successful topical cyclosporin A in the therapy of progressive vascularising keratitis in keratitis-ichthyosis-deafness (KID) syndrome (Senter syndrome)]. Klin Monbl Augenheilkd (2002) 0.91
The role of serology in active ocular toxoplasmosis. Int Ophthalmol (2012) 0.90
Clinical spectrum of tuberculous optic neuropathy. J Ophthalmic Inflamm Infect (2012) 0.90
Subretinal neovascular membranes complicating uveitis: frequency, treatments, and visual outcome. Ocul Immunol Inflamm (2005) 0.89
The mystery of angiographically silent macular oedema due to taxanes. Int Ophthalmol (2012) 0.89
Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease. Int Ophthalmol (2009) 0.88
Sensitivity of laser flare photometry compared to slit-lamp cell evaluation in monitoring anterior chamber inflammation in uveitis. Int Ophthalmol (2010) 0.88
Interferon-α therapy in noninfectious uveitis. Dev Ophthalmol (2012) 0.88
Pro-inflammatory cellular immune response in Behçet's disease. Rheumatol Int (2007) 0.87
Corticosteroid-induced central serous chorioretinopathy in patients with ocular inflammatory disorders. Klin Monbl Augenheilkd (2002) 0.87
Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol (2010) 0.87
Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study. Retina (2006) 0.86
Reappraisal of birdshot retinochoroiditis (BRC): a global approach. Graefes Arch Clin Exp Ophthalmol (2012) 0.86
Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results. Br J Ophthalmol (2014) 0.86
Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis. Adv Exp Med Biol (2003) 0.85
Behçet's disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol (2004) 0.85
Transpupillary thermotherapy for occult subfoveal neovessels in age-related macular degeneration: importance of patient pigmentation for the determination of laser settings. Klin Monbl Augenheilkd (2002) 0.85
Retinal vasculitis. Ocul Immunol Inflamm (2005) 0.85
Tuberculosis-related choriocapillaritis (multifocal-serpiginous choroiditis): follow-up and precise monitoring of therapy by indocyanine green angiography. Int Ophthalmol (2012) 0.85
Therapy of ocular Behçet disease. Ocul Immunol Inflamm (2013) 0.85
Editorial: Fuchs' uveitis: from Imperial Vienna to global appraisal. Int Ophthalmol (2010) 0.84
Interobserver agreement in scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation. Ocul Immunol Inflamm (2010) 0.84
Use of indocyanine green angiography in uveitis. Int Ophthalmol Clin (2012) 0.84
Idiopathic choroidal neovascularisation as the inaugural sign of multiple evanescent white dot syndrome. Middle East Afr J Ophthalmol (2010) 0.84
Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm (2014) 0.84
Central serous chorioretinopathy mistaken for tuberculous choroiditis. J Ophthalmic Vis Res (2011) 0.84
Bilateral intraocular calcification in necrotizing cytomegalovirus retinitis. Int Ophthalmol (2014) 0.83
Comparison of presenting features and three-year disease course in Turkish patients with Behçet uveitis who presented in the early 1990s and the early 2000s. Ocul Immunol Inflamm (2012) 0.83
Early and sustained treatment modifies the phenotype of birdshot retinochoroiditis. Int Ophthalmol (2013) 0.83
Bilateral acute iris transillumination following a fumigation therapy: a village-based traditional method for the treatment of ophthalmomyiasis. Cutan Ocul Toxicol (2014) 0.83
Current medical treatment of ocular mucous membrane pemphigoid. Ocul Surf (2013) 0.83
OCT findings in birdshot chorioretinitis: a glimpse into retinal disease evolution. Ophthalmic Surg Lasers Imaging (2012) 0.83
Fluorescein angiographic findings and clinical features in Fuchs' uveitis. Int Ophthalmol (2010) 0.83
Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.82
Is ICGA still relevant in inflammatory eye disorders? Why this question has to be dealt with separately from other eye conditions. Retina (2012) 0.82
Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey. Cornea (2010) 0.82
Choroidal neovascularization secondary to choroidal nevus simulating an inflammatory lesion. Indian J Ophthalmol (2013) 0.82
Treatment of ocular rosacea with once-daily low-dose doxycycline. Cornea (2014) 0.82
Unilateral papillitis, the tip of the iceberg of bilateral ICGA-detected tuberculous choroiditis. Ocul Immunol Inflamm (2011) 0.82
Mycophenolate sodium for immunosuppressive treatment in uveitis. Ocul Immunol Inflamm (2009) 0.81
Interferon-alpha-associated presumed ocular sarcoidosis. Graefes Arch Clin Exp Ophthalmol (2008) 0.81
Amphotericin B in the therapy of Candida glabrata endophthalmitis after penetrating keratoplasty. Cornea (2006) 0.81
Controversies in Behçet disease. Ocul Immunol Inflamm (2012) 0.80
Autoimmune retinopathies: a report of 3 cases. Ocul Immunol Inflamm (2013) 0.80
The good, the bad and the ugly--APCs of the eye. Trends Immunol (2003) 0.80
The creeping choroiditides - serpiginous and multifocal serpiginoid choroiditis. Ocul Immunol Inflamm (2014) 0.80
Editorial: Laser flare (cell) photometry: 20 years already. Int Ophthalmol (2010) 0.80
An unusual case of central serous chorioretinopathy in a patient with acute retinal necrosis. Ocul Immunol Inflamm (2008) 0.79
High incidence of antibodies to lens proteins in sera from patients with uveitis. Graefes Arch Clin Exp Ophthalmol (2006) 0.79
Intraocular lymphoma: more questions than answers. Ocul Immunol Inflamm (2009) 0.79
Necrotizing herpetic retinitis. Ocul Immunol Inflamm (2014) 0.79
New concepts in the appraisal and management of birdshot retinochoroiditis, a global perspective. Int Ophthalmol (2015) 0.78
Granulomatous keratic precipitates in birdshot retinochoroiditis. Int Ophthalmol (2012) 0.78
Presumed tuberculosis-induced retinal vasculitis, diagnosed with positron emission tomography (18F-FDG-PET/CT), aspiration biopsy, and culture. Ocul Immunol Inflamm (2010) 0.78
Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN. J Rheumatol (2005) 0.78
Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period. Pediatr Dermatol (2010) 0.78
Results of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behçet disease. J Ocul Pharmacol Ther (2007) 0.78